| Cause of death in the NLST and PLCO: comparison of death certificates and endpoint adjudication |
Pamela Marcus |
NCI |
NLST |
Nov 10, 2014 |
NLST-96 |
| Downstream testing and interventions in the NLST |
Vinay Prasad |
NCI |
NLST |
Nov 7, 2014 |
NLST-95 |
| Type 1 and Type 2 ovarian cancer in the PLCO Trial |
Keith Terada |
University of Hawaii |
PLCO |
Nov 4, 2014 |
PLCO-115 |
| Probabilistic risk prediction models and diagnostic prediction for lung cancer screening |
Alex Bui |
UCLA |
NLST |
Nov 3, 2014 |
NLST-93 |
| Study of racial disparities in colorectal cancer screening using flexible sigmoidoscopy and cancer outcomes: An analysis of the PLCO Cancer screening trial. |
Sejong Bae |
UAB |
PLCO |
Oct 29, 2014 |
PLCO-112 |
| An Econometric Evaluation of Prostate Cancer Treatments |
Michael Grossman |
CUNY and NBER |
PLCO |
Oct 20, 2014 |
PLCO-108 |
| Identifying Optimal Cohort for Renal Cell Cancer Screening |
Yair Lotan |
University of Texas Southwestern |
NLST |
Oct 9, 2014 |
NLST-92 |
| Identifying Optimal Cohort for Renal Cell Cancer Screening |
Yair Lotan |
University of Texas Southwestern |
PLCO |
Oct 9, 2014 |
PLCO-109 |
| Genome-Wide Predictors of Survival in Colorectal Cancer |
Polly Newcomb |
Fred Hutchinson Cancer Center |
PLCO |
Oct 7, 2014 |
PLCO-101 |
| A Comparative Cost-Effectiveness Analysis of Lung Cancer Screening by CT and Chest X-ray |
Gary Strauss |
Tufts Medical Center |
NLST |
Oct 2, 2014 |
NLST-90 |
| A Comparative Cost-Effectiveness Analysis of Lung Cancer Screening by CT and Chest X-ray |
Gary Strauss |
Tufts Medical Center |
PLCO |
Oct 2, 2014 |
PLCO-107 |
| The Association of 5 Alpha Reductase Inhibitor Use and the Natural History of Bladder Cancer |
Michael Liss |
University of Texas Health Science Center San Antonio |
PLCO |
Oct 2, 2014 |
PLCO-110 |
| Multiparametric image analysis and correlation with biopsy outcome |
Michael Folkert |
UT Southwestern Medical Center |
NLST |
Sep 29, 2014 |
NLST-91 |
| Examining the Relationships between Physical Activity Variables and Cancer Screening and Risk in the PLCO Trial |
Rebecca Simmons |
University of Utah |
PLCO |
Sep 9, 2014 |
PLCO-106 |
| Pre-diagnostic obesity, smoking and lymph node involvement at breast cancer diagnosis. |
Ian Barron |
Johns Hopkins |
PLCO |
Sep 9, 2014 |
PLCO-99 |
| HFHS Electronic Medical Records compared to HFHS PLCO data |
Melody Eide |
Henry Ford Health System |
PLCO |
Sep 9, 2014 |
PLCO-105 |
| The influence of inflammatory diets on the incidence of colorectal cancer, with special consideration of race and obesity |
Alyson Haslam |
University of Georgia |
PLCO |
Sep 4, 2014 |
PLCO-104 |
| Prospective Evaluation of Immune-related Markers and Gallbladder Cancer |
Jill Koshiol |
DCEG - Other |
PLCO |
Sep 3, 2014 |
2014-0198 |
| Circulation miRNA for Pancreatic Cancer Early Detection and Risk Assessment |
Xiao Ou Shu |
- |
PLCO |
Sep 3, 2014 |
2014-0190 |
| Endogenous Hormone Levels and Risk of Liver Cancer |
Katherine McGlynn |
NCI, DCEG, HREB |
PLCO |
Sep 3, 2014 |
2014-0187 |
